Samaniego], [Nicole Norma Gamarra-Valverde], [Andrea Tripoli], [Juan Pinilla], [Macarena Lopez], [Vinh Quang Tri Ho], and [Salomon Chamay]
If you are experiencing persistent eye irritation, vision changes, or swelling while taking this medication, do not discontinue your prescription without consulting your prescribing physician
FDA prescribing information for Mounjaro (tirzepatide) , the official label containing approved dosing, contraindications, and clinical trial data
Commonly Reported Injection site irritation: Redness, swelling, or itching at the subcutaneous injection site is the most frequent issue
Side Effects and Safety Considerations While generally considered safe when administered under medical supervision, glutathione injections for purposes like skin lightening are not FDA-approved due to insufficient clinical evidence supporting their efficacy and long-term safety specifically for cosmetic use
AD is characterized by the accumulation of amyloid-beta (A) plaques and neurofibrillary tangles composed of hyperphosphorylated tau protein [152]
